<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02105493</url>
  </required_header>
  <id_info>
    <org_study_id>NORAO2014</org_study_id>
    <nct_id>NCT02105493</nct_id>
  </id_info>
  <brief_title>Nitroglycerin Prevents Radial Artery Occlusion</brief_title>
  <acronym>NORAO</acronym>
  <official_title>A Novel Approach to Reduce Radial Artery Occlusion After Trans-Radial Catheterization: Post-Procedural/Pre-Hemostasis Intra-Arterial Nitroglycerin</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cardiovascular Center Harapan Kita Hospital Indonesia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cardiovascular Center Harapan Kita Hospital Indonesia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Trans-radial approach (TRA) has becoming popular and widely adopted over the last decade.
      However, radial artery occlusion (RAO) continues to be one of the limitation of trans-radial
      access and potentially limits the radial artery as an access site in the future. Several
      strategies have been used to decrease the incidence of RAO including the use of
      anticoagulation, maintenance of patency during hemostasis, or shortening the duration of
      compression. Currently, there is no data whether vasoactive pharmacological therapy such as
      nitroglycerin administered intra-arterially at the end of the procedure may reduce the
      incidence of RAO. It is hypothesized that the addition of nitroglycerin (nitric oxide donor)
      at the end of a TRA procedure may reduce the incidence of RAO.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Actual">March 2014</completion_date>
  <primary_completion_date type="Actual">February 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of radial artery occlusion as confirmed by absence of antegrade flow in vascular high resolution ultrasound</measure>
    <time_frame>One Day After the Index Procedure</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1706</enrollment>
  <condition>Injury of Radial Artery</condition>
  <arm_group>
    <arm_group_label>500 microgram of Nitroglycerin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>500 mcg nitroglycerin was given intra-arterially through the sheath at the end of a transradial procedure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline 5 mL</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>0,9% Saline 5 mL was given intra-arterially through the sheath at the end of a transradial procedure</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>500 microgram of Nitroglycerin</intervention_name>
    <description>500 microgram of Nitroglycerin (in 5 mL saline) given intra-arterially through the sheath at the end of transradial procedure</description>
    <arm_group_label>500 microgram of Nitroglycerin</arm_group_label>
    <other_name>NTG</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline 5 mL</intervention_name>
    <description>Saline 5 mL given intra-arterially through the sheath at the end of transradial procedure</description>
    <arm_group_label>Saline 5 mL</arm_group_label>
    <other_name>NaCl 0,9% 5mL</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Sequential patients undergoing trans-radial catheterization in the institution will be
             consented to be randomized to receive either 500 microgram nitroglycerin (Group A) or
             a placebo (Group B) administered intra-arterially through the sheath at the end of the
             procedure.

        Exclusion Criteria:

          -  Patients with cardiogenic shock or hemodynamically unstable

          -  Unable to tolerate nitrates
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Surya Dharma, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Cardiovascular Center Harapan Kita</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Cardiovascular Center Harapan Kita</name>
      <address>
        <city>Jakarta</city>
        <zip>11420</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Indonesia</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 19, 2014</study_first_submitted>
  <study_first_submitted_qc>April 2, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 7, 2014</study_first_posted>
  <last_update_submitted>April 2, 2014</last_update_submitted>
  <last_update_submitted_qc>April 2, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 7, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Cardiovascular Center Harapan Kita Hospital Indonesia</investigator_affiliation>
    <investigator_full_name>Surya Dharma, MD, PhD</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Nitroglycerin</keyword>
  <keyword>Radial Artery Occlusion</keyword>
  <keyword>Transradial Catheterization</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nitroglycerin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

